{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "marketState": "PRE", "exchange": "PNK", "regularMarketChangePercent": 6.7114167, "regularMarketPrice": 0.0159, "firstTradeDateMilliseconds": 1602682200000, "priceHint": 4, "earningsTimestampStart": 1684234740, "earningsTimestampEnd": 1684584000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.66, "epsForward": -1.39, "epsCurrentYear": -2.39, "priceEpsCurrentYear": -0.00665272, "sharesOutstanding": 36829600, "bookValue": 1.057, "fiftyDayAverage": 0.1858, "fiftyDayAverageChange": -0.1699, "fiftyDayAverageChangePercent": -0.9144241, "twoHundredDayAverage": 0.79003, "twoHundredDayAverageChange": -0.77413, "twoHundredDayAverageChangePercent": -0.97987413, "marketCap": 585590, "forwardPE": -0.011438849, "priceToBook": 0.015042573, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "shortName": "Codiak BioSciences, Inc.", "longName": "Codiak BioSciences, Inc.", "messageBoardId": "finmb_314148703", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": 0.0010000011, "regularMarketTime": 1684178491, "regularMarketDayHigh": 0.0159, "regularMarketDayRange": "0.012 - 0.0159", "regularMarketDayLow": 0.012, "regularMarketVolume": 55143, "regularMarketPreviousClose": 0.0149, "fullExchangeName": "Other OTC", "financialCurrency": "USD", "regularMarketOpen": 0.012, "averageDailyVolume3Month": 1571876, "averageDailyVolume10Day": 144290, "fiftyTwoWeekLowChange": 0.007900001, "fiftyTwoWeekLowChangePercent": 0.9875, "fiftyTwoWeekRange": "0.008 - 4.25", "fiftyTwoWeekHighChange": -4.2341, "fiftyTwoWeekHighChangePercent": -0.9962588, "fiftyTwoWeekLow": 0.008, "fiftyTwoWeekHigh": 4.25, "displayName": "Codiak BioSciences", "symbol": "CDAKQ"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "35 Cambridge Park Drive", "address2": "Suite 500", "city": "Cambridge", "state": "MA", "zip": "02140", "country": "United States", "phone": "617 949 4100", "website": "https://www.codiakbio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics S.A.S., Washington University, Ragon Institute of MGH, MIT, and Harvard. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. On March 27, 2023, Codiak BioSciences, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.", "fullTimeEmployees": 102, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sriram  Sathyanarayanan Ph.D.", "age": 50, "title": "Chief Scientific Officer", "yearBorn": 1972, "fiscalYear": 2021, "totalPay": {"raw": 502174, "fmt": "502.17k", "longFmt": "502,174"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 412165, "fmt": "412.17k", "longFmt": "412,165"}}, {"maxAge": 1, "name": "Ms. Linda Cathavina Bain CPA", "age": 52, "title": "Treasurer", "yearBorn": 1970, "fiscalYear": 2021, "totalPay": {"raw": 602539, "fmt": "602.54k", "longFmt": "602,539"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1044366, "fmt": "1.04M", "longFmt": "1,044,366"}}, {"maxAge": 1, "name": "Dr. Konstantin  Konstantinov Ph.D.", "age": 63, "title": "Chief Technology Officer", "yearBorn": 1959, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Christopher J. M. Taylor", "title": "VP of Investor Relations & Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Nicole  Barna", "age": 48, "title": "Sr. VP of HR", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. David J. Mauro M.D., Ph.D.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 4, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}